Carbapenem-resistant Gram-negative bacteria (CR-GNB) have emerged and disseminated worldwide, become a great concern worldwide including Korea. The prevalence of fecal carriage of imipenem-resistant Gram-negative bacteria (IR-GNB) in persons in Korea was investigated. Stool samples were collected from 300 persons upon medical examination. Samples were screened for IR-GNB by using MacConkey agar with 2 μl/ml imipenem. Species were identified by 16S rRNA gene sequence analysis, and antimicrobial susceptibility was determined by the broth microdilution method. In total, 82 IR-GNB bacterial isolates were obtained from 79 (26.3%) out of 300 healthy persons. Multilocus sequence typing analysis showed very high diversity among IR P. aeruginosa, S. maltophilia, and E. cloacae isolates, and pulsed-field gel electrophoresis revealed five main pulsotypes of IR P. mirabilis. As for the presence of metallo-β-lactamases (MBLs), only one IMP-25-producing S. marcescens isolate was identified. Although only one carbapenemase-producing isolate was identified, the high colonization rates with IR-GNB isolates in this study is notable because carriers may be a reservoir for the dissemination of resistant pathogens within the community as well as in health care institutions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12275-017-6555-8 | DOI Listing |
Lett Appl Microbiol
December 2024
Laboratory of Biotechnology, Chulabhorn Research Institute, Bangkok 10210, Thailand.
Sphingobium sp. SM42 Esterase B (EstB) is an enzyme with a dual function in degrading dibutyl phthalate and catalyzing the cleavage of the C-S bond in C3-sidechains of the dihydrothiazine ring of cephalosporins, generating more active β-lactam derivatives. Global prokaryotic genome analysis revealed the existence of a gene identical to estB in Pseudomonas aeruginosa strain PS1 suggesting a horizontal gene transfer event involving estB.
View Article and Find Full Text PDFPLoS One
October 2024
Department of Laboratory Medicine, Sanggye Paik Hospital, School of Medicine, Inje University, Seoul, South Korea.
Microbiol Spectr
October 2024
UMR Processus Infectieux en Milieu Insulaire Tropical, CNRS 9192, INSERM U1187, IRD 249, Université de La Réunion, Saint-Denis, La Réunion, France.
JAC Antimicrob Resist
February 2024
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Background: This study evaluated the activity of cefiderocol, ceftazidime/avibactam, and aztreonam/avibactam against clinically important multidrug-resistant non-fermenting Gram-negative bacilli.
Methods: Bacteraemic isolates of 126 multidrug-resistant (MDRAB), 110 imipenem-resistant [including 14 difficult-to-treat resistant (DTRPA)], 45 beta-lactam-non-susceptible complex (BCC), 47 levofloxacin or trimethoprim/sulfamethoxazole-non-susceptible and 22 ciprofloxacin-non-susceptible spp. collected between 2019 and 2021 were subjected to MIC determination for cefiderocol, ceftazidime/avibactam and aztreonam/avibactam.
Foodborne Pathog Dis
October 2023
Molecular Bacteriology Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!